Gastroduodenal tolerability of medium dose enteric-coated aspirin: A placebo controlled endoscopic study of a new enteric-coated formulation versus regular formulation in healthy volunteers

Fundamental and Clinical Pharmacology

Volumn 14, Issue 2, 2000, Pages 155-157

  Blondon, Hugues ^a   Barbier, Jean Philippe ^b   Mahé, Isabelle ^a   Deverly, Anne ^c   Kolsky, Hélène ^c   Bergmann, Jean François ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

^b Hopital Laennec   (France)

^c Bayer Pharma   (France)

Author keywords

Aspirin; Controlled trial; Endoscopy; Enteric coated; Gastrotoxicity; Healthy volunteers

Indexed keywords

ACETYLSALICYLIC ACID;

ADULT; ANALGESIA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG FORMULATION; DRUG SAFETY; DRUG TOLERABILITY; ENDOSCOPY; ENTERIC COATED TABLET; FEMALE; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL TOXICITY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SCORING SYSTEM;

EID: 0034128496     PISSN: 07673981     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2000.tb00404.x     Document Type: Article

References (6)

1. [1] Patrono C., Coller B., Dalen J.E. et al., Platelet-active drugs. The relationships among dose, effectiveness and side effects, Chest 114 (1998) 470S-488S.
2. [2] Hawthorne A.B., Mahida Y.R., Cole A.T., Hawkey C.J., Aspirin-induced gastric mucosal damage: prevention by enteric-coating and relation to prostaglandin synthesis, Br. J. Clin. Pharmacol. 32 (1991) 77-83.
3. [3] Lanza F.L., A double-bind study of prophylactic effect of misoprostol on lesions of gastric and duodenal mucosa induced by oral administration of tolmetin in healthy subjects, Dig. Dis. Sci. 31 (suppl. 2) (1986) 131S-136S.
4. [4] Petroski D., Endoscopic comparison of three aspirin preparations and placebo, Clin. Ther. 15 (1993) 314-320.
5. [5] Kelly J.P., Kaufman D.W., Jurgelon J.M., Sheehan J., Koff R.S., Shapiro S., Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product, Lancet 348 (1996) 1413-1416.
6. [6] Taylor D.W., Barnett H.J.M., Haynes R.B. et al., For the ASA and carotid Endarteriectomy (ACE) Trial Collaborators. Low-dose and high-dose acetylsalicylic acid for patients undergoing carotid endarteriectomy: a randomised controlled trial, Lancet 353 (1999) 2179-2184.